瘤透淋巴细胞治疗是否可以改善晚期黑色素瘤患者的生存结果?
1School of Medicine, Swansea University, Swansea, United Kingdom.
Frontiers in medicine
|February 20, 2026
概括
瘤透淋巴细胞 (TIL) 疗法对晚期黑色素瘤具有前景,提供有效的二线治疗选择. 虽然总体上是成功的,但建议对更大的研究和成本效益进行进一步的研究,以便获得英国的批准.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 癌症治疗方法 癌症治疗方法
背景情况:
- 转移性黑色素瘤是一种侵袭性癌症,在一线治疗失败后,治疗选择有限.
- 检查点阻塞免疫疗法 (抗PD-1,抗CTLA4) 显示有效性,但可能导致耐药性.
- 瘤透淋巴细胞 (TIL) 疗法是晚期黑色素瘤的新兴二线治疗方法.
研究的目的:
- 评估TIL治疗转移性和晚期黑色素瘤的有效性.
- 评估TIL治疗在英国获得批准的潜力,在最近FDA批准了Iifileucel (Amtagvi) 之后.
主要方法:
- 对Medline和Cochrane图书馆数据库的文献评论.
- 搜索术语:"瘤透淋巴细胞疗法"和"晚期黑色素瘤".
- 纳入标准:同行评审的研究,II/III期试验 (2015-2025年),英语,生存结果.
主要成果:
- TIL疗法在晚期黑色素瘤中表现出有效性,完全响应率高达20%.
- 研究表明,TIL疗法与对照疗法一样有效或更成功.
- 报告了一些不良反应,主要与淋巴细胞消耗化学疗法有关.
结论:
- TIL疗法代表了晚期黑色素瘤的突破性治疗方法,在一线治疗失败后提供了可行的选择.
- 需要进一步的研究,包括更大的队列研究和成本效益分析,以支持英国的批准.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.9K
10:03Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
Published on: November 11, 2016
10.3K
相关概念视频
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
02:17The Tumor Microenvironment
7.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K